UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Which index funds deliver the best after-tax returns in 2024 retirement scenarios by balancing tax efficiency, tracking accuracy, and costs.
28,168 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
VW's 100,000-job layoff plan signals a broader shift in auto manufacturing. As Chinese EVs tighten market share, inve...
Is Nike losing its spark in performance running? This article dives into whether nike lost edge performance and what ...
NWN’s Q1 2026 results reveal how the company balances growth with profitability. This analysis breaks down the number...
Memory-chip demand has surged with AI and cloud growth, but timing still matters. This guide breaks down how to evalu...
General Dynamics outpaced Lockheed Martin in Q1 2026 results, driven by submarines and jets. The gap in backlogs high...
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
A sharp divergence in the online brokerage space emerges in 2026 as Robinhood declines while Interactive Brokers gain...
A new Monte Carlo analysis maps XRP price paths through 2027 using 10,000 simulations, highlighting how regulatory ac...
Meta unveils a $6.5 billion plan to manufacture next-gen MTIA AI chips with Samsung Foundry, aiming to strengthen its...
The Jets ETF has breached critical chart support, suggesting airline stocks face risks beyond rising fuel costs. Tech...
Vice Capital Markets launches a public daily Par Note Rate benchmark, providing a market-based view of mortgage prici...